Cancer | Page 30 of 103 | SpiritIndia.com

Cancer :: Tumor vessels identified by unique molecular markers

Results from a new study have made it easier for scientists to distinguish between growing blood vessels in healthy tissues and those that are associated with tumors. This is a significant finding because this distinction, particularly at a molecular level, has remained elusive for quite some time. The research, released in the June issue of the journal Cancer Cell, published by Cell Press, has exciting implications for development of more selective vascular-targeted anticancer therapeutics.

Cancer :: How tumor cells home in on the lymphatic system

A Swiss-based research team has published a new mechanistic description of how tumor cells migrate to the lymphatic system in the early stages of tumor metastasis. This new understanding holds significant potential for developing anti-metastasis therapies.

Cancer :: GlaxoSmithKline & Adolor update alvimopan development programme

The U.S. Food and Drug Administration (FDA) has requested that additional data be submitted as part of the complete response to the November 6, 2006 approvable letter for alvimopan in postoperative ileus (POI).

Cancer :: Celebrate cancer survivors on June 10

The University of Michigan Comprehensive Cancer Center will host its annual Cancer Survivors Day celebration on Sunday, June 10 at Washtenaw Community College. Cancer Survivors Day is a national event which began in 1987 as a way of inspiring current cancer patients and showing the world that life after a cancer diagnosis is possible.

Cancer :: Aspirin use, but not NSAIDS, associated with reduced cancer risk

In a prospective study, aspirin use was associated with lower risk of cancer incidence and mortality, particularly among former and non-smokers.

Breast Cancer :: Inflammation protein is not associated with breast cancer risk

C-reactive protein (CRP), a marker of inflammation, is not associated with breast cancer risk among healthy women, despite earlier studies that suggest a link between chronic inflammation to breast cancer development.

Cancer :: Mutations to integrin ?7 gene may promote cancer development

A protein called integrin ?7 suppresses tumor growth and cell migration, and mutations in the integrin ?7 gene are identified in various cancers, including prostate and liver cancer.

Lung Cancer :: Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer

Some patients with advanced non?small-cell lung cancer (NSCLC) have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute.

Breast Cancer :: Diet and exercise key to surviving breast cancer, regardless of obesity

Breast cancer survivors who eat a healthy diet and exercise moderately can reduce their risk of dying from breast cancer by half, regardless of their weight, suggests a new longitudinal study from the Moores Cancer Center at the University of California, San Diego (UCSD).

Lung Cancer :: Encouraging results of GSK’s cancer drug in lung cancer patients

GlaxoSmithKline (GSK) announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC).